The inhibition of human plasmin by human antithrombin-heparin cofactor.
D000990:Antithrombin III / Q000378:metabolism / Q000494:pharmacology; D000991:Antithrombins / Q000494:pharmacology*; D001120:Arginine / Q000378:metabolism; D002364:Caseins / Q000378:metabolism; D004355:Drug Stability; D004357:Drug Synergism; D004591:Electrophoresis, Polyacrylamide Gel; D005341:Fibrinolysin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007457:Iodine Radioisotopes; D007700:Kinetics; D010084:Oxidation-Reduction; D011489:Protein Denaturation; D012967:Sodium Dodecyl Sulfate; D013329:Structure-Activity Relationship; D014105:Tosyl Compounds / Q000378:metabolism
D000991:Antithrombins; D002364:Caseins; D007457:Iodine Radioisotopes; D014105:Tosyl Compounds; D012967:Sodium Dodecyl Sulfate; D000990:Antithrombin III; D006493:Heparin; D001120:Arginine; D005341:Fibrinolysin